Highlights TheraVet SA

Equities

ALVET

BE0974387194

Real-time Euronext Paris Other stock markets 03:43:57 2024-06-18 EDT			5-day change	1st Jan Change
0.518 ^EUR	-0.38%		-10.07%	-64.28%

05-21	TheraVet SA Announces Early Completion of Patient Recruitment of the Visco-VET Clinical Study	CI
05-07	FOMO is Back

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

TheraVet SA Announces Early Completion of Patient Recruitment of the Visco-VET Clinical Study	05-21	CI
TheraVet SA Reports Earnings Results for the Full Year Ended December 31, 2023	04-23	CI
TheraVet SA Announces the Launch of BIOCERA-VET Equine	03-13	CI
TheraVet’s Veterinary Medicinal Product Gets Patents in Europe, Singapore, Israel	01-30	MT
Global markets live: Charles Schwab, Apple, Spirit Airlines, BP, Visa...	01-17
TheraVet SA Announces Commercial Launch of Biocera-VET in Germany	01-17	CI
Global markets live: Boeing, GSK, Hays, Shell, Eli Lilly...	01-09
TheraVet Announces Agreement with Alcyon Italia for the Distribution of BIOCERA-VET® Product Line in Italy	01-09	CI
TheraVet: positive feedback in canine osteosarcoma	01-04	CF
TheraVet SA Announces Launch of Biocera-Vet Canine Osteosarcoma Study Conducted by the University of Florida	11-23	CI
TheraVet Recruits Patients for Study on Bone Substitute Use in Dog Revision Surgery	23-09-27	MT
TheraVet SA Announces Patient Recruitment Phase Successfully Completed in Biocera-Vet Fracture Revision Surgery Study in Toy Dogs	23-09-27	CI
TheraVet SA Reports Earnings Results for the Half Year Ended June 30, 2023	23-09-06	CI
TheraVet SA Announces the Commercial Launch of A Local and Sustained Antibiotic Releasing Bone Substitute	23-05-31	CI
TheraVet SA Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-25	CI
TheraVet Kicks Off Reference Program for Bone Cancer in Dogs	23-04-06	MT
Theravet Signs Global Distribution Deal for Bone Substitutes for Dogs; Shares Up 52%	23-02-21	MT
TheraVet Signs an International Distribution Agreement for BIOCERA-VET® Covering 24 Countries	23-02-21	CI
TheraVet, Elvetis Strike Distribution Deal for Bone Substitutes Product Range in France	22-12-12	MT
TheraVet Signs New Exclusive Distribution Agreement for Its Line of Bone Substitutes BIOCERA-VET® with Elvetis	22-12-12	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights TheraVet SA

Equities

ALVET

BE0974387194

Highlights

Filters